JP2015509945A5 - - Google Patents

Download PDF

Info

Publication number
JP2015509945A5
JP2015509945A5 JP2014558870A JP2014558870A JP2015509945A5 JP 2015509945 A5 JP2015509945 A5 JP 2015509945A5 JP 2014558870 A JP2014558870 A JP 2014558870A JP 2014558870 A JP2014558870 A JP 2014558870A JP 2015509945 A5 JP2015509945 A5 JP 2015509945A5
Authority
JP
Japan
Prior art keywords
changed
ala
composition
asp
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014558870A
Other languages
English (en)
Japanese (ja)
Other versions
JP6309902B2 (ja
JP2015509945A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/027336 external-priority patent/WO2013130349A1/en
Publication of JP2015509945A publication Critical patent/JP2015509945A/ja
Publication of JP2015509945A5 publication Critical patent/JP2015509945A5/ja
Application granted granted Critical
Publication of JP6309902B2 publication Critical patent/JP6309902B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014558870A 2012-02-27 2013-02-22 ランチビオティクスmu1140および改善された薬理学的特性および構造的特徴を有する他のランチビオティクスの変異体 Active JP6309902B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261603693P 2012-02-27 2012-02-27
US201261603661P 2012-02-27 2012-02-27
US61/603,661 2012-02-27
US61/603,693 2012-02-27
PCT/US2013/027336 WO2013130349A1 (en) 2012-02-27 2013-02-22 Variants of the lantibiotic mu1140 and other lantibiotics with improved pharmacological properties and structural features

Publications (3)

Publication Number Publication Date
JP2015509945A JP2015509945A (ja) 2015-04-02
JP2015509945A5 true JP2015509945A5 (cg-RX-API-DMAC10.html) 2016-04-07
JP6309902B2 JP6309902B2 (ja) 2018-04-11

Family

ID=49083172

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014558872A Expired - Fee Related JP6297506B2 (ja) 2012-02-27 2013-02-22 齲歯のための置換療法
JP2014558870A Active JP6309902B2 (ja) 2012-02-27 2013-02-22 ランチビオティクスmu1140および改善された薬理学的特性および構造的特徴を有する他のランチビオティクスの変異体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014558872A Expired - Fee Related JP6297506B2 (ja) 2012-02-27 2013-02-22 齲歯のための置換療法

Country Status (10)

Country Link
US (2) US9260488B2 (cg-RX-API-DMAC10.html)
EP (3) EP3219325B1 (cg-RX-API-DMAC10.html)
JP (2) JP6297506B2 (cg-RX-API-DMAC10.html)
CN (2) CN104302307B (cg-RX-API-DMAC10.html)
AU (2) AU2013226402B2 (cg-RX-API-DMAC10.html)
BR (2) BR112014020659A2 (cg-RX-API-DMAC10.html)
CA (2) CA2865395A1 (cg-RX-API-DMAC10.html)
HK (2) HK1205519A1 (cg-RX-API-DMAC10.html)
MX (2) MX358060B (cg-RX-API-DMAC10.html)
WO (2) WO2013130349A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019529344A (ja) * 2016-07-15 2019-10-17 イントレキソン コーポレーション ランチビオティックバリアントおよびその使用
US10577399B2 (en) 2016-10-28 2020-03-03 The Texas A&M University System Modified lantibiotics and methods of making and using the modified lantibiotics
WO2020090045A1 (ja) * 2018-10-31 2020-05-07 株式会社村田製作所 抗グラム陰性菌化合物
AU2019371455B2 (en) * 2018-11-01 2022-01-13 Biofouling Technologies, Inc. Durable biofouling protection
CA3128389A1 (en) * 2019-03-08 2020-09-17 Fraunhofer Usa, Inc. Novel antimicrobial lantibiotic peptide and uses thereof
CN118490568B (zh) * 2024-07-16 2024-10-18 南昌怀特科技有限公司 一种用于牙齿美白的抑菌凝胶及其制备方法与应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US5516682A (en) 1988-07-05 1996-05-14 University Of Maryland Subtilin variant of enhanced stability and activity
GB9423404D0 (en) 1994-11-19 1995-01-11 Biotech & Biolog Scien Res Production of nisin
US20060198793A1 (en) 1997-06-10 2006-09-07 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
US6964760B2 (en) 1997-06-10 2005-11-15 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
US5932469A (en) * 1997-06-10 1999-08-03 University Of Florida Antimicrobial polypeptide, nucleic acid, and methods of use
US6251478B1 (en) 1999-12-22 2001-06-26 Balchem Corporation Sensitive substance encapsulation
EP1483366B1 (en) * 2002-02-22 2010-04-14 Blis Technologies Limited Antimicrobial composition
US20090215985A1 (en) * 2005-08-12 2009-08-27 Oragenics, Inc. Differentially protected orthogonal lanthionine technology
EP1915389B1 (en) 2005-08-12 2011-06-08 Oragenics, Inc. Differentially protected orthogonal lanthionine technology
WO2007044745A1 (en) 2005-10-11 2007-04-19 Biosynexus Incorporated Lantibiotic and mupirocin compositions for treating bacterial infections
WO2008151434A1 (en) * 2007-06-12 2008-12-18 The University Of British Columbia Small cationic antimicrobial peptides
AU2008319177B2 (en) * 2007-07-20 2012-07-05 Regents Of The University Of Minnesota Lantibiotics from bifidobacterium longum and uses thereof
IE20080365A1 (en) * 2008-05-09 2010-03-16 Univ College Cork Nat Univ Ie Nisin derivatives and the use thereof

Similar Documents

Publication Publication Date Title
TWI455721B (zh) 癌疫苗組合物
US8828413B2 (en) Peptoid oligomers, pharmaceutical compositions and methods of using the same
JP2010516688A5 (cg-RX-API-DMAC10.html)
US8901071B2 (en) Compounds and their use
KR102224929B1 (ko) 해삼에서 분리한 항균 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
JP2013520405A5 (cg-RX-API-DMAC10.html)
JP7219512B2 (ja) 抗菌活性を有するポリペプチド、これを含む敗血症の予防または治療用組成物、および抗菌用組成物
JP2018512454A5 (cg-RX-API-DMAC10.html)
JP2013518057A5 (cg-RX-API-DMAC10.html)
JP2016518351A5 (cg-RX-API-DMAC10.html)
CN115244067A (zh) 合成抗微生物肽
AU2020227591B2 (en) Polypeptide having antibacterial activity, composition for preventing or treating sepsis comprising same, and antibacterial composition
CN108704119A (zh) 一种杀灭口腔致龋菌及抑制牙菌斑形成的抗菌肽及其应用
US20220195001A1 (en) Novel antimicrobial and anti-cancer therapy
AU2008211788A1 (en) Basic peptides and their use as combined antibacterial-antifungine agents
JP6309902B2 (ja) ランチビオティクスmu1140および改善された薬理学的特性および構造的特徴を有する他のランチビオティクスの変異体
PH12015502005A1 (en) New stable pentadecapeptide salts, a process for preparation thereof, a use thereof in the manufacture of pharmaceutical preparations and a use thereof in therapy
IL303954B1 (en) Fimh mutants, compositions therewith and use thereof
JP2019523220A5 (cg-RX-API-DMAC10.html)
SI3191504T1 (en) Ezrine-derived peptides and their pharmaceutical compositions
EP2297195B9 (en) Antibacterial peptides
US20250296961A1 (en) Antimicrobial peptides for remineralization of teeth and prevention of dental caries
JP5518899B2 (ja) 抗微生物活性を有するメラノコルチンアナログ
JP2014515751A5 (cg-RX-API-DMAC10.html)
CN101389642B (zh) 环状抗微生物肽